James B. Young focuses on Internal medicine, Heart failure, Cardiology, Heart disease and Surgery. His work in Internal medicine is not limited to one particular discipline; it also encompasses Placebo. His Heart failure research includes themes of Blood pressure, Intensive care medicine, Ambulatory, Hazard ratio and Inotrope.
His research investigates the connection between Cardiology and topics such as Central venous pressure that intersect with issues in Cardiac output. His research integrates issues of Diabetes mellitus, Mortality rate, Atrial fibrillation, Candesartan and Heart rate in his study of Heart disease. His work deals with themes such as Relative risk, Ventricular assist device, Renal function and Risk factor, which intersect with Surgery.
James B. Young mainly investigates Internal medicine, Cardiology, Heart failure, Transplantation and Surgery. His studies in Ejection fraction, Coronary artery disease, Hazard ratio, Ventricular assist device and Hemodynamics are all subfields of Internal medicine research. His research in Cardiology intersects with topics in Ambulatory, Anesthesia and Asymptomatic.
His work in Heart failure tackles topics such as Intensive care medicine which are related to areas like Disease. His Transplantation research includes themes of Gastroenterology, Intravascular ultrasound, Vascular disease and Pathology. His research is interdisciplinary, bridging the disciplines of Risk factor and Surgery.
The scientist’s investigation covers issues in Heart failure, Internal medicine, Cardiology, Ventricular assist device and In patient. James B. Young works in the field of Heart failure, namely Ejection fraction. His research ties Diabetes mellitus and Internal medicine together.
His research on Cardiology frequently connects to adjacent areas such as Clinical endpoint. In the subject of general Ventricular assist device, his work in Destination therapy is often linked to Continuous flow, thereby combining diverse domains of study. His Destination therapy research incorporates themes from Annual report and Adverse effect.
His scientific interests lie mostly in Internal medicine, Heart failure, Cardiology, Destination therapy and Ventricular assist device. Hazard ratio, Cohort, Transplantation, Heart transplantation and Clinical endpoint are the core of his Internal medicine study. His research in Heart failure is mostly focused on Cardiac resynchronization therapy.
His studies examine the connections between Cardiology and genetics, as well as such issues in Renal function, with regards to Creatinine and Candesartan. His research on Destination therapy also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.
James B. Young;William T. Abraham;Andrew L. Smith;Angel R. Leon.
JAMA (2003)
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness
James A. Hill;Daniel F. Pauly;Debra R. Olitsky;Stuart Russell.
JAMA (2005)
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
Guillermo Torre-Amione;Samir Kapadia;Claude Benedict;Hakan Oral.
Journal of the American College of Cardiology (1996)
Comparison of candesartan, enalapril, and their combination in congestive heart failure : randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study : the RESOLVD Pilot Study Investigators
R. S. McKelvie;S. Yusuf;D. Pericak;A. Avezum.
Circulation (1999)
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
Guillermo Torre-Amione;Samir Kapadia;Joseph Lee;Jean Bernard Durand.
Circulation (1996)
Cytokines and Cytokine Receptors in Advanced Heart Failure An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST)
Anita Deswal;Nancy J. Petersen;Arthur M. Feldman;James B. Young.
Circulation (2001)
Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
Wilfried Mullens;Zuheir Abrahams;Gary S. Francis;George Sokos.
Journal of the American College of Cardiology (2009)
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Gregg C. Fonarow;Wendy Gattis Stough;William T. Abraham;Nancy M. Albert.
Journal of the American College of Cardiology (2007)
Seventh INTERMACS annual report: 15,000 patients and counting
James K. Kirklin;David C. Naftel;Francis D. Pagani;Robert L. Kormos.
Journal of Heart and Lung Transplantation (2015)
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.
Daniel E. Forman;Javed Butler;Yongfei Wang;William T. Abraham.
Journal of the American College of Cardiology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cleveland Clinic
Northwestern University
Cleveland Clinic
The Ohio State University
University of Alabama at Birmingham
Northwestern University
University of Alabama at Birmingham
Vanderbilt University Medical Center
Cleveland Clinic
Northwestern University
Brunel University London
Hong Kong Polytechnic University
University of Cambridge
Polytechnic University of Milan
South China Normal University
Niigata University of Pharmacy and Applied Life Sciences
École Normale Supérieure
National Oceanography Centre
Inserm : Institut national de la santé et de la recherche médicale
University of Chicago
Columbia University
Université Catholique de Louvain
University of Pittsburgh
University of Michigan–Ann Arbor
Harvard University
University of Westminster